Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN)
- 1 April 2020
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 85, 101992
Abstract
No abstract availableKeywords
Funding Information
- Fonds De La Recherche Scientifique - FNRS (/FNRS 7650918F)
This publication has 81 references indexed in Scilit:
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel SequencingClinical Chemistry, 2013
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersNature, 2012
- Quantitation of Human Papillomavirus DNA in Plasma of Oropharyngeal Carcinoma PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy NumberAnalytical Chemistry, 2011
- Detection and quantification of rare mutations with massively parallel sequencingProceedings of the National Academy of Sciences, 2011
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinomaOral Oncology, 2008
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004